MEN4 (previously termed MENX) was initially discovered in a rat [49], which developed highly penetrant multiple neuroendocrine tumors within the first year of life, with the causative gene (CDKN1B) discovered a few years later [50]. Here, CDKN1B is linked to neuroendocrine neoplasm.